Study Into Genetic Influence on Cholesterol Response to Dietary Fat
NCT01384032 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88
Last updated 2011-06-28
Summary
Cardiovascular disease (CVD) is recognised as one of the main causes of death in the western world. LDL- cholesterol ('bad' cholesterol) and other lipids (fats) are important CVD risk factors. Apolipoprotein E (apoE) is an important transporter of fats in the blood. ApoE comes in E2, E3 and E4 forms, depending on your genetic make up. Approximately 60% of the UK population are E3/E3, 25% E4 carriers and 15% E2 carriers. There is some evidence to suggest that an E4 genotype may put you at modestly higher risk of CVD. Furthermore although very inconclusive previous studies have suggested that E4 individuals are slightly more sensitive to the LDL-cholesterol modifying effects of dietary fats (saturated fat, total fat, fish oil) showing slightly, greater reductions when low levels of these fat are consumed, and greater increases when high levels of these fat are consumed. Therefore, the aims of the Satgene study is to examine the impact of modifications in dietary total fat and saturated fat intakes, alone and in combination with fish oil supplement on LDL-cholesterol and other blood lipids, in individuals with an E3 and E4 genotype. The levels of total fat and saturated fat used in the current study are within the range observed in a typical UK population.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Low fat diet
Subjects were asked to consume a low fat diet for 8 weeks. Composition: 28% energy from fat, 8% energy from saturated fat, 55% energy from carbohydrate. Subjects were provided with low fat spread, cooking oil and snacks and asked to consume these in place of normally eaten equivalent foods. Subjects were asked to consume two extra portions of carbohydrate per day (e.g. two slices of bread, equivalent to 35g carbohydrate) and to consume low fat dairy products. Subjects also consumed 2g control oil per day during this period. Control oil comprised palm olein and soybean oil.
- DIETARY_SUPPLEMENT
-
Hgih saturated fat diet
Subjects were asked to consume a high saturated fat diet for 8 weeks. Composition: 38% energy from fat, 18% energy from saturated fat, 45% energy from carbohydrate. Subjects were provided with spread, cooking oil and snacks and asked to consume these in place of normally eaten equivalent foods. Subjects were asked to consume one less portion of carbohydrate per day (e.g. one slice of bread and to consume full fat dairy products. Subjects also consumed 2g control oil per day during this period. Control oil comprised palm olein and soybean oil.
- DIETARY_SUPPLEMENT
-
High saturated fat diet
Subjects were asked to consume a high saturated fat diet for 8 weeks. Composition: 38% energy from fat, 18% energy from saturated fat, 45% energy from carbohydrate. Subjects were provided with spread, cooking oil and snacks and asked to consume these in place of normally eaten equivalent foods. Subjects were asked to consume one less portion of carbohydrate per day (e.g. one slice of bread and to consume full fat dairy products. Subjects also consumed 6g DHA-rich oil per day during this period providing 3g DHA.
Sponsors & Collaborators
-
Wellcome Trust
collaborator OTHER -
University of Reading
lead OTHER
Principal Investigators
-
Julie A Lovegrove, Professor · University of Reading
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 35 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-01-31
- Primary Completion
- 2010-10-31
- Completion
- 2011-05-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Apolipoprotein Polymorphisms and Risk of Coronary Heart Disease
NCT00005225 ·Status: COMPLETED
-
Genetic Epidemiology of Lipoprotein-Lipid Levels
NCT00005335 ·Status: COMPLETED
-
Epidemiology of APO- and Lipoproteins in Elderly Women
NCT00005223 ·Status: COMPLETED
-
Genetic and Environmental Determinants of Triglycerides (GOLDN)
NCT00083369 ·Status: COMPLETED
-
Longitudinal LDL-C Studies in Black and White Families
NCT00007384 ·Status: COMPLETED
-
Pooling of Cohort Studies on Diet & Coronary Disease
NCT00006309 ·Status: COMPLETED
-
Assessment of Lipoprotein(a) and Endogenous Fibrinolysis in Atherosclerotic Cardiovascular Disease/Aortic Valve Disease
NCT06126367 ·Status: RECRUITING
-
Longitudinal Interaction Between APOA5 -1131T>C and Overweight Accelerates Arterial Stiffness
NCT03367598 ·Status: COMPLETED
-
Re-evaluating Triglycerides in Coronary Heart Disease
NCT00005442 ·Status: COMPLETED
-
Genetic Mapping of Atherogenic Lipoprotein Phenotypes
NCT00005465 ·Status: COMPLETED
-
EAS Familial Hypercholesterolaemia Studies Collaboration
NCT04272697 ·Status: RECRUITING
-
Physiological Effects of ANGPTL3 Variants in Humans
NCT04234724 ·Status: RECRUITING ·Phase: NA
-
Genetics of CVD Risk Factors in Samoans
NCT00005528 ·Status: COMPLETED
-
Epidemiology of Genetic Factors in Lipid Metabolism
NCT00005214 ·Status: COMPLETED
-
Genetic Polymorphisms Associated With CAD
NCT02307422 ·Status: UNKNOWN
-
Prognostic Hemodynamic and Metabolic Profiles of Late Stage Lower Extremity Arterial Disease
NCT04143386 ·Status: RECRUITING
-
Prognostic Models for People With Stable Coronary Artery Disease
NCT01609465 ·Status: UNKNOWN
-
Genetic- and Biological-Markers of Predisposition to Atherosclerosis: Leipzig-Heart Study
NCT00497887 ·Status: UNKNOWN
-
Genetic Epidemiology of CVD Risk Factors
NCT00053521 ·Status: COMPLETED
-
The Effects of Renal Function and Atrial Fibrillation on Lipoproteins and Clot Structure/Function
NCT04043026 ·Status: TERMINATED
-
Genetics of Low Density Lipoprotein Subclasses in Hypercholesterolemia
NCT00005203 ·Status: COMPLETED
-
Identifying Genes That May Increase the Risk for Heart Disease in African Americans
NCT00344136 ·Status: COMPLETED
-
Dyslipidemia and Risk of Cardiovascular Disease in Diabetic Men and Women
NCT00037258 ·Status: COMPLETED
-
Genetic Predictors of Incident Cardiovascular Disease
NCT00035672 ·Status: WITHDRAWN
-
Role and Interactions of Adenosine, Receptors, Methionine Cycle Nutritional, Metabolic and Genetic Determinants in the Onset of Atrial Fibrillation in Normal Heart
NCT02885740 ·Status: UNKNOWN ·Phase: NA